Viit https://telehealthfx.com to get started.

Educational content only — not medical advice. Talk to a licensed clinician before starting any medication. Telehealth FX is an informational and affiliate platform, not a medical provider or pharmacy, and may earn a commission. Compounded medications are not FDA-approved. Individual results vary.

Semaglutide goes by a lot of names — Ozempic, Wegovy, Rybelsus, and now the new Wegovy pill — and the confusion is real. In this episode we explain what semaglutide actually is, how it works, the difference between the brands, how well it works for weight management, what the research says about heart health, how it compares to tirzepatide, the real side effects, and the honest truth about what happens when you stop.

Quick clarifier: semaglutide is the active drug. Ozempic is the injection approved for type 2 diabetes; Wegovy is the injection approved for weight management; Rybelsus is the oral tablet for type 2 diabetes. In December 2025 the FDA approved a once-daily oral semaglutide (Wegovy pill) for chronic weight management.

Key facts: In the STEP 1 trial, average weight loss with semaglutide 2.4 mg injection was about 14.9% over 68 weeks. In the OASIS 4 trial, the oral 25 mg pill produced about 13.6% average weight loss (around 16.6% with full adherence), described as similar to the injection. In the SELECT trial, semaglutide was linked to about a 20% reduction in major cardiovascular events in people with overweight/obesity and established heart disease. In the head-to-head SURMOUNT-5 trial, semaglutide produced about 13.7% weight loss versus 20.2% for tirzepatide. Across follow-up studies, people regained roughly two-thirds of lost weight within a year of stopping.

Real risks discussed: gastrointestinal side effects; a boxed warning for thyroid C-cell tumors (not for those with a personal/family history of medullary thyroid carcinoma or MEN2); pancreatitis and gallbladder risks; and an eye-condition signal still under study.

Important: Compounded semaglutide is not FDA-approved — the FDA does not evaluate it for safety, effectiveness, or quality — and it is not the same as branded Ozempic or Wegovy. Prescription medications require evaluation and a prescription from a licensed clinician, and eligibility is individual. Individual results vary.

Learn more or see if you may qualify at https://telehealthfx.com

#Semaglutide #Ozempic #Wegovy #Rybelsus #WeightManagement #GLP1 #HealthEducation #Telehealth